See more : Bilendi SA (ALBLD.PA) Income Statement Analysis – Financial Results
Complete financial analysis of CSL Limited (CMXHF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of CSL Limited, a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- James Cropper PLC (CRPR.L) Income Statement Analysis – Financial Results
- Summa Silver Corp. (SSVR.V) Income Statement Analysis – Financial Results
- Argonaut Resources NL (AGREF) Income Statement Analysis – Financial Results
- Höegh LNG Holdings Ltd. (HLNG.OL) Income Statement Analysis – Financial Results
- SIM Technology Group Limited (SIMTF) Income Statement Analysis – Financial Results
CSL Limited (CMXHF)
About CSL Limited
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants for the treatment of immunodeficiency, bleeding disorders, hereditary angioedema, Alpha-1 antitrypsin deficiency, and neurological disorders. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14.80B | 13.17B | 10.49B | 7.71B | 6.31B | 5.95B | 5.59B | 5.06B | 4.41B | 4.15B | 5.01B | 4.58B | 4.59B | 4.79B | 3.19B | 2.98B | 3.27B | 2.28B | 1.56B | 1.59B | 813.90M | 596.56M | 427.09M | 433.49M | 0.00 | 0.00 | 0.00 | 238.52M | 221.82M | 178.49M | 140.52M | 112.46M |
| Cost of Revenue | 7.13B | 6.47B | 4.83B | 3.35B | 2.72B | 2.63B | 2.60B | 2.55B | 2.26B | 1.98B | 2.45B | 2.21B | 2.37B | 2.43B | 1.56B | 1.55B | 1.77B | 1.25B | 932.74M | 973.98M | 526.43M | 375.14M | 258.90M | 243.65M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 7.67B | 6.71B | 5.66B | 4.35B | 3.59B | 3.32B | 2.99B | 2.52B | 2.14B | 2.17B | 2.57B | 2.37B | 2.22B | 2.35B | 1.63B | 1.43B | 1.50B | 1.03B | 627.59M | 613.89M | 287.47M | 221.41M | 168.19M | 189.84M | 0.00 | 0.00 | 0.00 | 238.52M | 221.82M | 178.49M | 140.52M | 112.46M |
| Gross Profit Ratio | 51.83% | 50.92% | 53.97% | 56.49% | 56.88% | 55.80% | 53.46% | 49.71% | 48.65% | 52.26% | 51.19% | 51.69% | 48.26% | 49.16% | 50.97% | 48.08% | 45.77% | 45.23% | 40.22% | 38.66% | 35.32% | 37.12% | 39.38% | 43.79% | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Research & Development | 1.43B | 1.24B | 1.16B | 751.84M | 638.71M | 581.46M | 517.02M | 493.97M | 457.94M | 351.86M | 438.17M | 394.51M | 367.57M | 371.66M | 226.85M | 201.05M | 206.78M | 137.19M | 88.19M | 84.14M | 49.78M | 41.87M | 29.64M | 41.74M | 0.00 | 0.00 | 0.00 | 27.42M | 23.83M | 19.31M | 17.48M | 12.73M |
| General & Administrative | 825.00M | 1.09B | 688.00M | 549.35M | 479.35M | 401.81M | 378.94M | 371.11M | 304.62M | 218.63M | 273.95M | 258.82M | 238.66M | 245.60M | 170.73M | 262.76M | 231.15M | 138.10M | 268.21M | 100.81M | 64.46M | 42.14M | 32.51M | 46.36M | 0.00 | 0.00 | 0.00 | 1.77M | 0.00 | 0.00 | 0.00 | 7.96M |
| Selling & Marketing | 1.56B | 1.45B | 960.70M | 735.92M | 620.98M | 605.93M | 578.71M | 533.54M | 463.24M | 378.93M | 474.43M | 477.15M | 505.91M | 503.05M | 350.53M | 315.59M | 363.83M | 268.62M | 186.14M | 191.90M | 72.04M | 51.32M | 30.57M | 34.38M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 2.38B | 2.54B | 1.65B | 1.29B | 1.10B | 1.01B | 957.64M | 904.65M | 767.86M | 597.56M | 748.38M | 735.97M | 744.57M | 748.65M | 521.26M | 578.36M | 594.98M | 406.72M | 454.35M | 292.71M | 136.50M | 93.46M | 63.08M | 80.75M | 0.00 | 0.00 | 0.00 | 1.77M | 0.00 | 0.00 | 0.00 | 7.96M |
| Other Expenses | 82.00M | 136.00M | 81.60M | 33.56M | 34.85M | 20.06M | 240.99M | 235.00M | 284.93M | 116.96M | 159.15M | 138.38M | 154.69M | 120.78M | 93.57M | 228.12M | 194.30M | 77.54M | 16.88M | 176.99M | 55.37M | 182.99K | -16.33M | -325.79M | 0.00 | 31.52M | 25.13M | -238.52M | -173.62M | -138.80M | -114.87M | -73.19M |
| Operating Expenses | 3.89B | 4.61B | 3.35B | 2.41B | 2.03B | 1.85B | 1.69B | 1.52B | 1.39B | 1.09B | 1.37B | 1.32B | 1.29B | 1.31B | 860.29M | 886.34M | 932.01M | 615.03M | 606.11M | 475.42M | 274.54M | 190.14M | 128.68M | 20.88M | 11.96M | 31.52M | 25.13M | 52.46M | 18.24M | 13.62M | 5.48M | 4.80M |
| Cost & Expenses | 10.99B | 11.07B | 8.18B | 5.76B | 4.75B | 4.48B | 4.29B | 4.07B | 3.65B | 3.07B | 3.82B | 3.53B | 3.66B | 3.74B | 2.43B | 2.43B | 2.70B | 1.86B | 1.54B | 1.45B | 800.97M | 565.28M | 387.58M | 264.53M | 11.96M | 31.52M | 25.13M | 52.46M | 18.24M | 13.62M | 5.48M | 4.80M |
| Interest Income | 39.00M | 38.00M | 17.40M | 2.93M | 4.85M | 9.65M | 6.85M | 8.34M | 10.37M | 11.86M | 18.88M | 27.18M | 42.56M | 32.41M | 29.00M | 40.93M | 32.31M | 23.85M | 13.95M | 9.93M | 4.69M | 316.11K | 1.22M | -0.12 | 0.00 | 0.00 | 0.00 | -0.63 | -0.37 | -0.39 | -0.37 | -0.65 |
| Interest Expense | 484.22M | 408.00M | 142.80M | 128.23M | 104.49M | 123.52M | 79.79M | 68.89M | 53.42M | 45.32M | 49.79M | 44.09M | 40.48M | 16.55M | 13.00M | 39.94M | 45.74M | 32.48M | 22.74M | 24.04M | 11.68M | 15.66M | 10.63M | 7.63M | 116.82K | 314.28K | 267.83K | 1.49M | 2.34M | 2.11M | 581.48K | 8.96K |
| Depreciation & Amortization | 938.00M | 831.00M | 542.50M | 407.30M | 290.88M | 262.42M | 218.40M | 123.55M | 164.36M | 137.87M | 183.10M | 186.35M | 177.57M | 189.85M | 112.18M | 106.93M | 130.25M | 71.13M | 63.57M | 98.57M | 63.95M | 54.80M | 35.96M | 20.88M | 11.96M | 0.00 | 0.00 | 23.28M | 18.24M | 13.62M | 5.48M | 4.80M |
| EBITDA | 4.73B | 3.90B | 3.46B | 2.72B | 2.18B | 2.02B | 1.98B | 1.49B | 1.38B | 1.49B | 1.74B | 1.59B | 1.48B | 1.58B | 1.11B | 1.03B | 1.05B | 660.02M | 179.67M | 493.28M | 200.91M | 117.00M | 96.31M | 56.35M | 40.95M | 31.52M | 25.13M | 29.74M | 46.05M | 31.81M | 17.73M | 14.09M |
| EBITDA Ratio | 31.98% | 29.62% | 33.02% | 35.35% | 34.54% | 34.00% | 35.40% | 29.34% | 31.27% | 35.81% | 34.72% | 34.68% | 32.20% | 32.92% | 34.88% | 34.56% | 32.15% | 28.94% | 11.50% | 31.04% | 24.68% | 19.61% | 22.55% | 8.18% | 0.00% | 0.00% | 0.00% | 12.47% | 20.76% | 17.82% | 12.62% | 12.53% |
| Operating Income | 3.81B | 3.07B | 2.92B | 2.72B | 1.89B | 1.76B | 1.76B | 1.36B | 1.21B | 1.35B | 1.56B | 1.40B | 1.30B | 1.39B | 1.00B | 923.69M | 920.21M | 588.90M | 115.87M | 394.30M | 136.95M | 62.20M | 60.36M | 14.59M | 28.99M | 31.52M | 25.13M | 6.47M | 27.81M | 18.20M | 12.25M | 9.29M |
| Operating Income Ratio | 25.76% | 23.31% | 27.85% | 35.35% | 29.93% | 29.59% | 31.49% | 26.90% | 27.54% | 32.49% | 31.07% | 30.61% | 28.33% | 28.96% | 31.37% | 30.97% | 28.17% | 25.82% | 7.43% | 24.83% | 16.83% | 10.43% | 14.13% | 3.37% | 0.00% | 0.00% | 0.00% | 2.71% | 12.54% | 10.19% | 8.72% | 8.26% |
| Total Other Income/Expenses | -437.00M | 561.00M | 463.50M | 280.12M | 226.09M | 168.61M | 386.44M | 298.00M | 406.24M | 221.37M | 311.34M | 307.81M | 334.34M | 326.49M | 221.74M | 336.04M | 311.12M | 164.21M | 71.89M | 232.20M | 112.34M | -15.66M | -10.63M | 13.25M | -116.82K | 0.00 | 0.00 | -210.27M | -2.34M | -2.11M | -581.48K | -8.96K |
| Income Before Tax | 3.38B | 2.66B | 2.78B | 2.22B | 1.78B | 1.64B | 1.68B | 1.29B | 1.16B | 1.30B | 1.51B | 1.36B | 1.26B | 1.37B | 988.03M | 883.75M | 874.47M | 556.41M | 93.36M | 370.67M | 125.27M | 46.54M | 49.72M | 27.84M | 28.87M | 31.20M | 24.86M | 28.26M | 25.47M | 16.09M | 11.66M | 9.28M |
| Income Before Tax Ratio | 22.80% | 20.21% | 26.49% | 28.87% | 28.27% | 27.51% | 30.06% | 25.54% | 26.33% | 31.40% | 30.07% | 29.64% | 27.45% | 28.61% | 30.96% | 29.63% | 26.77% | 24.40% | 5.98% | 23.34% | 15.39% | 7.80% | 11.64% | 6.42% | 0.00% | 0.00% | 0.00% | 11.85% | 11.48% | 9.01% | 8.30% | 8.25% |
| Income Tax Expense | 661.00M | 419.00M | 524.90M | 441.54M | 325.80M | 295.28M | 406.54M | 269.76M | 233.90M | 254.75M | 279.30M | 232.10M | 242.49M | 294.36M | 233.89M | 144.40M | 229.84M | 168.75M | 29.09M | 370.67M | 125.27M | 46.54M | 49.72M | 27.84M | 28.87M | 31.20M | 24.86M | 28.26M | 25.47M | 16.09M | 11.66M | 9.28M |
| Net Income | 2.64B | 2.19B | 2.25B | 1.78B | 1.46B | 1.34B | 1.27B | 1.02B | 926.93M | 1.05B | 1.23B | 1.12B | 1.02B | 1.08B | 754.14M | 739.34M | 644.63M | 387.66M | 64.28M | 315.57M | 108.05M | 32.22M | 39.35M | 20.52M | 19.49M | 21.03M | 17.19M | 19.86M | 0.00 | -3.54K | 5.85K | 6.20M |
| Net Income Ratio | 17.85% | 16.65% | 21.49% | 23.14% | 23.10% | 22.55% | 22.78% | 20.22% | 21.02% | 25.26% | 24.50% | 24.57% | 22.16% | 22.46% | 23.63% | 24.79% | 19.73% | 17.00% | 4.12% | 19.87% | 13.28% | 5.40% | 9.21% | 4.73% | 0.00% | 0.00% | 0.00% | 8.33% | 0.00% | 0.00% | 0.00% | 5.51% |
| EPS | 5.45 | 4.55 | 4.81 | 3.94 | 3.21 | 2.96 | 2.81 | 2.25 | 2.01 | 2.22 | 2.54 | 2.26 | 1.96 | 1.99 | 1.33 | 1.24 | 1.17 | 0.71 | 0.12 | 0.54 | 0.20 | 0.07 | 0.08 | 0.05 | 0.05 | 0.05 | 0.04 | 0.05 | 0.05 | 0.00 | 0.03 | 0.03 |
| EPS Diluted | 5.45 | 4.53 | 4.80 | 3.93 | 3.20 | 2.96 | 2.80 | 2.24 | 2.00 | 2.22 | 2.53 | 2.25 | 1.95 | 1.99 | 1.32 | 1.24 | 1.16 | 0.70 | 0.12 | 0.54 | 0.20 | 0.07 | 0.08 | 0.04 | 0.05 | 0.05 | 0.04 | 0.05 | 0.05 | 0.00 | 0.03 | 0.03 |
| Weighted Avg Shares Out | 484.77M | 482.17M | 468.75M | 454.87M | 453.81M | 452.92M | 452.35M | 455.33M | 462.00M | 471.82M | 483.82M | 498.61M | 519.23M | 540.53M | 566.78M | 595.24M | 550.11M | 547.71M | 546.08M | 587.96M | 534.52M | 477.51M | 474.99M | 448.57M | 400.11M | 394.21M | 399.29M | 397.95M | 395.39M | 393.61M | 316.79M | 237.63M |
| Weighted Avg Shares Out (Dil) | 485.20M | 484.33M | 469.73M | 456.20M | 455.58M | 454.02M | 453.90M | 456.29M | 463.06M | 471.82M | 485.69M | 500.33M | 520.31M | 541.82M | 568.55M | 597.65M | 553.25M | 551.43M | 546.08M | 590.83M | 536.54M | 479.07M | 479.26M | 460.24M | 408.02M | 401.54M | 399.29M | 397.95M | 395.39M | 393.61M | 316.79M | 237.63M |
No news found for: CMXHF
Source: https://incomestatements.info
Category: Stock Reports